Parkinsons disease drug therapies in the clinical trial pipeline: 2022 update
Gene Therapy - P.I.K.N.I.C, The University of Texas MD Anderson Cancer Center, Houston, T, 1999
Dedicated eye products from reputable peptide vendors or medical-grade lines typically deliver better results with fewer complications than attempting to adapt facial serums for eye use
FDA-approved GLP-1 receptor agonists, such as Ozempic, Wegovy, and older drugs like liraglutide (Saxenda, Victoza) and dulaglutide (Trulicity), have revolutionized treatment by enabling: Better blood sugar control in type 2 diabetes patients Weight loss support through appetite regulation and delayed digestion Potential reduction in cardiovascular risk for some patients While these drugs have become increasingly popular for metabolic health care, they can come with side effects like gastrointestinal discomfort, and must be taken under medical supervision
We encourage you to actively engage with your health journey, armed with knowledge and supported by our expert team